Oligasis, LLC
Oligasis, LLC is listed today as Kodiak Sciences Inc.: market value, financials and filings are on its company page.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2015 | $34 M | No. 2 | $10 to $50 million | equity | SEC | |
| Jul 2009 | $2 M | No. 1 | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Oligasis, LLC chose not to state its revenue in its newest notice of a funding round (Mar 2016).
SEC Form D · Mar 2016
The industry group it chose in its notices: Biotechnology.
SEC Form D · Mar 2016
That is all the official record says: Oligasis, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Oligasis, LLC are on record.
Investors#
5 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| 667, L.P. | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner, director (Form 3, 2018) | SEC Form 3 |
| Baker Bros. Advisors (GP) LLC | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner, director (Form 3, 2018) | SEC Form 3 |
| Baker Bros. Advisors LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner, director (Form 3, 2018) | SEC Form 3 |
| Baker Brothers Life Sciences LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner, director (Form 3, 2018) | SEC Form 3 |
| Victor Perlroth | Person | not stated | not stated | Held Series A preferred stock, 10% owner, director (Form 3, 2018) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 26 investors.
Largest shareholders today
Institutions holding Kodiak Sciences Inc. shares, as of Sep 30, 2026.
- Baker Bros. Advisors LP$2.1 B33.43%
- BlackRock, Inc.$362 M5.83%
- Price T Rowe Associates Inc /MD/$278 M4.49%
- State Street Corp$211 M3.41%
- Goldman Sachs Group Inc$189 M3.04%
- T. Rowe Price Investment Management, Inc.$187 M3.01%
- Janus Henderson Group Ltd.$178 M2.88%
- Vanguard Capital Management LLC$168 M2.72%
- RTW Investments, LP$141 M2.28%
- Boxer Capital Management, LLC$140 M2.26%
- TCG Crossover Management, LLC$137 M2.21%
- Braidwell LP$103 M1.66%
- Geode Capital Management, LLC$99 M1.59%
- Adage Capital Partners GP, L.L.C.$95 M1.53%
- Artisan Partners Limited Partnership$79 M1.28%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| John Borgeson | Executive officer | Mar 2016 |
| Steven Charles | Executive officer | Jul 2009 |
| Victor Perlroth | Executive officer | Jul 2009 |
| Steven Charles | Director | Jul 2009 |
| Victor Perlroth | Director | Jul 2009 |
About
Biotech company.
Went public since 2018. Its SEC number is that of a company listed on a stock exchange.